Violation Tracker Individual Record

Company: 
AbbVie Inc.
Current Parent Company: 
AbbVie
Penalty: 
$24,000,000
Year: 
2020
Date: 
August 6, 2020
Offense Group: 
consumer-protection-related offenses
Primary Offense: 
consumer protection violation
Violation Description: 

The California Insurance Commissioner resolved a lawsuit against AbbVie Inc. alleging violations of the California Insurance Frauds Prevention Act involving the marketing of the prescription drug HUMIRA. AbbVie agreed to reform its HUMIRA marketing practices in California, including disclosing that registered nurses employed as Ambassadors to interact with patients about HUMIRA are actually paid by the company, not a medical provider, and reforming how HUMIRA is marketed to health care providers. In addition, as provided for in the Act, AbbVie has also paid a combined $24 million to the State of California and the whistleblower who brought the case to the Department's attention.

Level of Government: 
state
Action Type: 
agency action
Agency: 
California Department of Insurance
Civil or Criminal Case: 
civil
Facility State: 
California
HQ Country of Parent: 
USA
HQ State of Parent: 
Illinois
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.